[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
:: Volume 21, Issue 2 (5-2016) ::
__Armaghane Danesh__ 2016, 21(2): 200-211 Back to browse issues page
Frequency of *4 allele in CYP2D6 gene and its Association with Ovarian Cancer Risk in Tehran, Iran
SH Helalat1, Kh Onsory *2, Z Haji Mehdi Nouri3
1- Young and Elite Researchers Club, Islamic Azad University, Parand Branch, Parand, Iran
2- Department of Biology, Islamic Azad University, Parand Branch, Parand, Iran , onsory@gmail.com
3- Cellular and Molecular Biology, Islamic Azad University, Sirjan Branch, Sirjan, Iran
Abstract:   (3994 Views)

Background & aim: CYP2D6 enzyme is one of the most important members of the cytochrome P450 superfamily which play an important role in the metabolism of many drugs. The CYP2D6 gene presents a high allele heterogeneity that significantly stimulated many changes between individuals in a population, so that classified into extensive, intermediate, or poor drug metabolizers. The CYP2D6*4 allele is the most common polymorphic allele of CYP2D6 gene which due to a nucleotide change of G→A )G1934→A(, resulting in a reduced or lack of activity of CYP iso-enzyme. The aim of this study was to evaluate the frequency of CYP2D6*4 allele among patient and control groups and to find out the relationship of this polymorphism with the risk of ovarian cancer patients in Tehran.

Methods: In the present case-control study, samples were collected in tubes containing EDTA. DNA is extracted from cancer tissue and blood controls group were performed. The frequency of CYP2D6*4 allele was determined among 120 patients who were admitted to Imam Khomeini Hospital by PCR-RFLP method and then compared with 125 normal controls who visited the same center. The collected data were analyzed using logistic regression analysis.

Results: The results show that the prevalence of patients group with poor metabolism of drugs (PM) 13.3%, heterozygotes extensive metabolizer (HEM) 23.3% and extensive metabolizer (EM) was 63.3% respectively. The results indicated no significant association was seen between HEM and ovarian cancer risk (OR=1.27; CI 95% ; 2.85-0.56; P=0.55). Also no association was observed between PM and risk of this disease among the studied population (OR=0.75; CI 95%; 1.38-0.41; P= 0.36).

Conclusion: There was no meaningful association between CYP2D6*4 allele which results in variations of G1934→A genetic polymorphism and ovarian cancer has been observed in the study population.

Keywords: CYP2D6*4 allele, Polymorphism, Ovarian cancer, PCR-RFLP
Full-Text [PDF 268 kb]   (1232 Downloads)    
Type of Study: Research | Subject: Special
Received: 2015/09/2 | Accepted: 2016/04/30 | Published: 2016/05/9
Send email to the article author

Add your comments about this article
Your username or Email:


XML   Persian Abstract   Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Helalat S, Onsory K, Haji Mehdi Nouri Z. Frequency of *4 allele in CYP2D6 gene and its Association with Ovarian Cancer Risk in Tehran, Iran. Armaghane danesh. 2016; 21 (2) :200-211
URL: http://armaghanj.yums.ac.ir/article-1-1036-en.html

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 21, Issue 2 (5-2016) Back to browse issues page
ارمغان دانش Armaghane danesh
Persian site map - English site map - Created in 0.04 seconds with 30 queries by YEKTAWEB 4355